Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
27.14
-2.05 (-7.02%)
At close: Jan 16, 2026, 4:00 PM EST
27.15
+0.01 (0.04%)
After-hours: Jan 16, 2026, 7:57 PM EST
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $2.13 billion as of January 16, 2026. Its market cap has increased by 396.41% in one year.
Market Cap
2.13B
Enterprise Value
1.81B
1-Year Change
396.41%
Ranking
Category
Stock Price
$27.14
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has increased from $1.79B to $2.13B, an increase of 18.96%. That is a compound annual growth rate of 3.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 2.13B | 8.56% |
| Dec 31, 2025 | 1.97B | 357.26% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |